Skip to Main Navigation
Skip to Page Content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Oral Comment Request

Webcast: Peer-Review Meeting of Draft NTP Developmental and Reproductive Toxicity Technical Reports on 2 Hydroxy-4-methoxybenzophenone (2H4MBP) and 2-Ethylhexyl p-Methoxycinnamate (EHMC)

Dates:

  • Meeting date is October 14, 2021 (10:00 a.m. – approximately 5:00 p.m. EDT)
    Note: Meeting may end sooner or last longer.
  • October 7, 2021 is the deadline to register to present oral comments.

For more information, read NTP's guidelines for public comments.

Maximum number of oral speakers:

The agenda allows for one public comment period per report:

  • Each public comment period is limited to 6 speakers.
  • Up to 5 minutes are allotted to each registered speaker per report (up to 6 speakers).
  • One speaker per organization is permitted per report.

Requests to provide oral comments are on a first-come, first-served basis (only one speaker per organization per topic session). After the maximum number of speakers is reached, the requestors will be placed on a waitlist. Individuals will be notified should an opening become available.

OMB#: 0925-0740 Exp Date: 07/2022

Collection of this information is authorized by The Public Health Service Act, Section 411 (42 USC 285a). Rights of study participants are protected by The Privacy Act of 1974. Participation is voluntary, and there are no penalties for not participating or withdrawing from the study at any time. Refusal to participate will not affect your benefits in any way. The information collected in this study will be kept private to the extent provided by law. Names and other identifiers will not appear in any report of the study. Information provided will be combined for all study participants and reported as summaries. You are being contacted on-line to complete this instrument so that we can improve the website.

Public reporting burden for this collection of information is estimated to average no more than 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.

Note: Required denotes required information.

Provide personal information.

Personal Information

Personal Information

Your personal information will only be used as a means to identify you for the meeting.

Provide comment information.

Public Oral Comments Registration

Topic I: 2 Hydroxy-4-methoxybenzophenone (2H4MBP):
Topic II: 2-Ethylhexyl p-Methoxycinnamate (EHMC):

Information for Public Oral Comments Registration

Registration for Oral comments is due by October 7.

For more information, read NTP's guidelines for public comments.

Submit the form.